- Report
- October 2023
- 145 Pages
Global
From €2818EUR$3,150USD£2,478GBP
- Report
- October 2024
- 160 Pages
Global
From €5690EUR$6,360USD£5,002GBP
€7112EUR$7,950USD£6,253GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €2684EUR$3,000USD£2,360GBP
€3355EUR$3,750USD£2,950GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1431EUR$1,600USD£1,258GBP
€1789EUR$2,000USD£1,573GBP
- Report
- April 2024
- 30 Pages
China
From €1610EUR$1,800USD£1,416GBP
€2013EUR$2,250USD£1,770GBP
- Report
- April 2023
- 180 Pages
Global
From €2147EUR$2,400USD£1,888GBP
€2684EUR$3,000USD£2,360GBP
- Report
- September 2022
- 141 Pages
Global
From €3399EUR$3,800USD£2,989GBP
€4249EUR$4,750USD£3,736GBP
- Report
- February 2022
- 210 Pages
Global
From €5368EUR$6,000USD£4,719GBP
€6710EUR$7,500USD£5,899GBP
- Report
- April 2023
- 110 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 120 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 117 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 117 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- July 2021
- 116 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- June 2020
- 114 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- April 2023
- 115 Pages
Global
From €4249EUR$4,750USD£3,736GBP
- Report
- September 2025
- 88 Pages
India
From €3131EUR$3,500USD£2,753GBP
- Report
- August 2025
- 86 Pages
India
From €3131EUR$3,500USD£2,753GBP
- Report
- January 2025
- 80 Pages
India
From €3131EUR$3,500USD£2,753GBP
- Report
- August 2024
- 80 Pages
Japan
From €3131EUR$3,500USD£2,753GBP
The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
